Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Akronia Valley
Barcelona, Catalonia, Spainakroniavalley.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Akronia Valley is a Spanish biotechnology company focused on the discovery and development of novel small molecule therapeutics targeting G protein-coupled receptors (GPCRs). The company utilizes a proprietary drug discovery platform that combines advanced computational modeling with specialized biological assays to identify high-affinity ligands for challenging GPCR targets. Their primary research programs are directed toward addressing significant unmet needs in neuropathic pain and inflammatory disorders. By leveraging their expertise in receptor pharmacology, Akronia Valley aims to develop next-generation treatments with improved efficacy and reduced side-effect profiles compared to current standards of care.
- Therapeutic areas
- ImmunologyNeurology
- Modalities
- Small molecule
- Industry
- Biotech
Beyond the preview
Go deeper on Akronia Valley.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Akronia Valley.